Substance Use Treatment in the Era of New HIV Prevention Technologies
作者： David S. Metzger
DOI: 10.1007/978-1-4614-8845-3_8
关键词: Injection drug use 、 Global challenges 、 Sexual transmission 、 Intensive care medicine 、 Substance use 、 Substance use treatment 、 Acquired immunodeficiency syndrome (AIDS) 、 Viral load 、 Human immunodeficiency virus (HIV) 、 Medicine
摘要: From the start of AIDS epidemic, a variety strategies have been implemented in an attempt respond to reduce transmissions among drug users, but these efforts narrowly defined, are limited scope and focused almost exclusively on injection use related risks. The role non-injection substance sustaining sexual transmission inhibiting effective antiretroviral treatment has underestimated since first cases HIV infection were identified. Substance remains one greatest global challenges risk reduction, access retention care, adherence medications, sustained suppression viral load. This chapter reviews accomplishments discusses opportunities facing scale-up prevention technologies regards addressing impact use. Three major topics will be addressed: (1) defining challenge, (2) medication-assisted treatments for disorders as technologies, (3) scale-up.
springer.com
sci-hub.st 参考文章(67)
A. Grigoryan, T. Durant, L. Espinoza, X. Wei, M. Chen, T. D. Mastro, R. L. Shouse, T. Kajese, H. I. Hall, HIV infection among injection-drug users - 34 states, 2004-2007. Morbidity and Mortality Weekly Report. ,vol. 58, pp. 1291- 1295 ,(2009)
Nicholas Meader, Ryan Li, Don C. Des Jarlais, Stephen Pilling, Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users Cochrane Database of Systematic Reviews. ,(2010) , 10.1002/14651858.CD007192.PUB2
David A. Fiellin, Michael V. Pantalon, Marek C. Chawarski, Brent A. Moore, Lynn E. Sullivan, Patrick G. O'Connor, Richard S. Schottenfeld, Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence The New England Journal of Medicine. ,vol. 355, pp. 365- 374 ,(2006) , 10.1056/NEJMOA055255
Loraine Townsend, Catherine Mathews, Yanga Zembe, A systematic review of behavioral interventions to prevent HIV infection and transmission among heterosexual, adult men in low-and middle-income countries. Prevention Science. ,vol. 14, pp. 88- 105 ,(2013) , 10.1007/S11121-012-0300-7
Beryl A Koblin, None, Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study The Lancet. ,vol. 364, pp. 41- 50 ,(2004) , 10.1016/S0140-6736(04)16588-4
D Fram, Naltrexone treatment--the problem of patient acceptance. Journal of Substance Abuse Treatment. ,vol. 6, pp. 119- 122 ,(1989) , 10.1016/0740-5472(89)90039-1
Paul G. Barnett, James L. Sorensen, Wynnie Wong, Nancy A. Haug, Sharon M. Hall, Effect of incentives for medication adherence on health care use and costs in methadone patients with HIV Drug and Alcohol Dependence. ,vol. 100, pp. 115- 121 ,(2009) , 10.1016/J.DRUGALCDEP.2008.09.017
Lynn E. Sullivan, David S. Metzger, Paul J. Fudala, David A. Fiellin, Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users Addiction. ,vol. 100, pp. 150- 158 ,(2005) , 10.1111/J.1360-0443.2004.00963.X
L. E. Sullivan, D. A. Fiellin, Buprenorphine: Its Role in Preventing HIV Transmission and Improving the Care of HIV-Infected Patients with Opioid Dependence Clinical Infectious Diseases. ,vol. 41, pp. 891- 896 ,(2005) , 10.1086/432888
George E. Woody, Sabrina A. Poole, Geetha Subramaniam, Karen Dugosh, Michael Bogenschutz, Patrick Abbott, Ashwin Patkar, Mark Publicker, Karen McCain, Jennifer Sharpe Potter, Robert Forman, Victoria Vetter, Laura McNicholas, Jack Blaine, Kevin G. Lynch, Paul Fudala, Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth JAMA. ,vol. 300, pp. 2003- 2011 ,(2008) , 10.1001/JAMA.2008.574